# US 2026/0076026 A1 · Organic electroluminescent materials and devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0076026 A1
- Document ID: US20260076026A1
- Status: Published application
- Kind: A1
- Application number: 19/320,050
- Filed: 2025-09-05
- Published: 2026-03-12
- Earliest claimed: 2024-09-11
- Assignees: Universal Display Corporation
- Applicants: Universal Display Corporation
- Inventors: Bin Ma; Hsiao-Fan Chen; Elena Sheina
- Web page: https://patentgrep.com/patent/US20260076026A1

## CPC

- H10K 50/121: {for assisting energy transfer, e.g. sensitization}
- C07F 15/0033: {Iridium compounds}
- C07F 15/0086: {Platinum compounds}
- H10K 50/11: characterised by the electroluminescent [EL] layers
- H10K 85/342: {comprising iridium}
- H10K 85/346: {comprising platinum}
- H10K 2101/10: Triplet emission
- H10K 2101/25: using exciplex
- H10K 2101/90: {Multiple hosts in the emissive layer}
- H10K: ORGANIC ELECTRIC SOLID-STATE DEVICES
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

Provided are organometallic compounds comprising a central metal atom which is coordinated by at least one ligand which is at least two-dentate and which comprises at least two 5-membered to 10-membered carbocyclic or heterocyclic rings. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

## Claims

### Claim 1

A compound having a first ligand LA comprising a structure of Formula I:
wherein moieties A and B are each independently a monocyclic ring or a polycyclic fused ring system, wherein the monocyclic ring or each ring of the polycyclic fused ring system is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring;
wherein Z1—Z4 are each independently C or N;
wherein K1 and K2 are each independently selected from the group consisting of a direct bond, O, S, N(Rα), P(Rα), B(Rα), C(Rα)(Rβ), and Si(Rα)(Rβ);
wherein L is selected from the group consisting of a direct bond, O, S, Se, NR, BR, BRR′, PR, CR, C═O, C═NR, C═CRR′, C═S, CRR′, SO, SO2, P(O)R, SiRR′, and GeRR′;
wherein RA and RB each independently represents mono to the maximum allowable substitution, or no substitution;
wherein each R, R′, Rα, Rβ, RA, and RB are each independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
wherein at least one of RA, RB, moiety A, or moiety B comprises a structure of Formula II:
wherein X1, X3, X4, and X6 are each independently selected from the group consisting of O, S, Se, N, NR, B, BR, BRR′, PR, C, CR, C═O, C═NR, C═CRR′, C═S, CRR′, S, SO, SO2, P, P(O)R, Si, SiRR′, Ge, and GeRR′;
wherein X2 and X5 are each independently selected from the group consisting of N, C and CR;
wherein Z is selected from the group consisting of O, S, Se, B, BR, BRR′, N, NR, C, CRR′, Si, SiRR′, Ge, and GeRR′;
wherein LA is coordinated to a metal M;
wherein represents a single bond or a double bond;
wherein exactly one of the bonds between X1 and X2 and the bond between X2 and X3 is a double bond;
wherein exactly one of the bonds between X4 and X5 and the bond between X5 and X6 is a double bond;
wherein M is selected from the group consisting of Ru, Os, Ir, Pd, Pt, Cu, Ag, and Au;
wherein M may be coordinated to other ligands;
wherein LA may be joined with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and
wherein any two of R, R′, Rα, Rβ, RA, and RB may be joined or fused to form a ring.

### Claim 2 (depends on 1)

The compound of claim 1, wherein each of R, R′, Rα, Rβ, RA, and RB is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof; and/or
wherein exactly two of X1 to X6 are heteroatoms; and/or wherein Z is selected from the group consisting of B, BR, BRR′, N, and NR.

### Claim 3 (depends on 1)

The compound of claim 1, wherein the structure of Formula II is selected from the group consisting of:
wherein X7 is CR7 or N, X8 is CR or N, X9 is CR9 or N, X10 is CR10 or N, X1 is CR1 or N, X2 is CR12 or N, X13 is CR13 or N, X14 is CR14 or N; and
each of Y1 and Y2 are each independently selected from the group consisting of O, S, Se, N, NR, B, BR, BRR′, PR, C, CR, C═O, C═NR, C═CRR′, C═S, CRR′, S, SO, SO2, P, P(O)R, Si, SiRR′, Ge, and GeRR′.

### Claim 4 (depends on 1)

The compound of claim 1, wherein the structure of Formula II is selected from the group consisting of:

### Claim 5 (depends on 1)

The compound of claim 1, wherein L is a direct bond; and/or wherein both of K1 and K2 are a direct bond.

### Claim 6 (depends on 1)

The compound of claim 1, wherein the ligand LA is selected from the group consisting of the structures as defined in LIST 1 as defined herein;
wherein
X7 is CR7 or N, X8 is CR8 or N, X9 is CR9 or N, X10 is CR10 or N, X11 is CR11 or N, X12 is CR12 or N, X13 is CR13 or N, X14 is CR14 or N, X15 is CR15 or N, X16 is CR16 or N, X17 is CR17 or N, X18 is CR18 or N;
each of Y1 and Y2 are each independently selected from the group consisting of O, S, Se, N, NR, B, BR, BRR′, PR, C, CR, C═O, C═NR, C═CRR′, C═S, CRR′, S, SO, SO2, P, P(O)R, Si, SiRR′, Ge, and GeRR′; and
each of RN and R7 to R18 is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

### Claim 7 (depends on 1)

The compound of claim 1, wherein the ligand LA is selected from the group consisting of structures as defined in LIST 2 as defined herein;
wherein each of R19 and R20 is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

### Claim 8 (depends on 1)

The compound of claim 1, wherein the ligand LA is selected from LAai-(Rl)(Rm)(Rn)(Ro)(Rp), wherein ai is an integer from 1 to 70, each of Rl, Rm, Rn, Ro, and Rp is independently selected from the group consisting of R1 to R468, and each of LA1-(R1)(R1)(R1)(R1)(R1) to LA70-(R468)(R468)(R468)(R468)(R468) is defined in the structures of LIST 3 as defined herein:
wherein R1 to R468 have the following structures as defined in LIST 9 as defined herein.

### Claim 9 (depends on 1)

The compound of claim 1, wherein the ligand LA is selected from the group consisting of the structures as defined in LIST 3a as defined herein;
wherein:
at least one of R, R′, Ra1, Rb1, Rc1, Rd1, Ra′, Rb′, Rc′, Rd′, Re, or Rf comprises a structure of Formula II;
T is selected from the group consisting of B, Al, Ga, and In;
W1 is selected from the group consisting of a direct bond, BR, NR, PR, O, S, Se, C═O, C═S, C═Se, C═NR, C═CRR′, S═O, SO2, CRR′, P(O)R, SiRR′, and GeRR′;
W2 is B, N, P, CR, SiR, or GeR;
K1′ is selected from the group consisting of a single bond, O, S, NRe, PRe, BRe, CReRf, and SiReRf;
each of Y1 to Y18 is independently selected from the group consisting of C and N;
each of Ya′, Y′, and Y″ is independently selected from the group consisting of BRe, BReRf, NRe, PRe, P(O)Re, O, S, Se, C═O, C═S, C═Se, C═NRe, C═CReRf, S═O, SO2, CReRf, SiReRf, and GeReRf;
each Ra′, Rb′, Rc′, and Rd′ independently represents from mono to the maximum allowed number of substitutions, or no substitution;
each of R, R′, Ra1, Rb1, Rc1, Rd1, Ra′, Rb′, Rc′, Rd′, Re, and Rf is independently a hydrogen or a subsituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, selenyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and
any two substituents of R, R′, Ra1, Rb1, Rc1, Rd1, Ra′, Rb′, Rc′, Rd′, Re, and Rf can be fused or joined to form a ring or form a multidentate ligand.

### Claim 10 (depends on 1)

The compound of claim 1, wherein the ligand LA is selected from the group consisting of the structures as defined in LIST 3b as defined herein;
wherein at least one of Ra′ or Rb′ comprises a structure of Formula II.

### Claim 11 (depends on 1)

The compound of claim 1, wherein the compound has a formula of M(LA)p(LB)q(LC)r wherein LB and LC are each a bidentate ligand; and wherein p is 1, 2, or 3; q is 0, 1, or 2; r is 0, 1, or 2; and p+q+r is the oxidation state of the metal M.

### Claim 12 (depends on 11)

The compound of claim 11, wherein LB and LC are each independently selected from the group consisting of the structures as defined in LIST 4 as defined herein;
wherein:
T is selected from the group consisting of B, Al, Ga, and In;
wherein K1′ is a direct bond or is selected from the group consisting of NRe, PRe, O, S, and Se;
each of Y1 to Y13 is independently selected from the group consisting of carbon and nitrogen;
Y′ is selected from the group consisting of BRe, NRe, PRe, O, S, Se, C═O, C═S, C═Se, S═O, SO2, P(O)Re, C═NRe, C═CReRf, CReRf, SiReRf, and GeReRf;
Re and Rf can be fused or joined to form a ring;
each Ra, Rb, Rc, and Rd independently represent zero, mono, or up to a maximum allowed number of substitutions to its associated ring;
each of Ra1, Rb1, Rc1, Rd1, Ra, Rb, Rc, Rd, Re and Rf is independently a hydrogen or a subsituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; the general substituents defined herein; and
any two adjacent Ra, Rb, Rc, Rd, Re and Rf can be fused or joined to form a ring or form a multidentate ligand.

### Claim 13 (depends on 11)

The compound of claim 11, wherein the compound comprises a structure of Formula III:
wherein:
M1 is Pd or Pt;
moieties E and F are each independently a monocyclic ring or a polycyclic fused ring system, wherein the monocyclic ring or each ring of the polycyclic fused ring system is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring;
Z5 and Z6 are each independently C or N;
K1, K2, K3, and K4 are each independently selected from the group consisting of a direct bond, O, S, N(Rα), P(Rα), B(Rα), C(Rα)(Rβ), and Si(Rα)(Rβ), wherein at least two of them are direct bonds;
L1, L2, and L3 are each independently selected from the group consisting of a single bond, absent a bond, O, S, CR′R″, SiR′R″, BR′, and NR′, wherein at least one of L1 or L3 is present;
RE and RF each independently represent zero, mono, or up to a maximum allowed number of substitutions to its associated ring;
each of Rα, Rβ, R′, R″, RE, and RF is independently a hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof;
two adjacent RA, RB, RE, and RF can be joined or fused together to form a ring where chemically feasible; and
Z1-Z4, L, RA, RB, moiety A and moiety B are all defined the same as above.

### Claim 14 (depends on 13)

The compound of claim 13, wherein the compound is selected from the group consisting of compounds having the formula of Pt(LA′)(Ly):
wherein LA′ is selected from the group consisting of the structures shown in LIST 12 as defined herein: wherein at least one of R, RA, or RB comprises a structure of Formula II;
wherein Ly is selected from the group consisting of the structures shown in LIST 13 as defined herein;
wherein each R, R′, R″, RA, RB, RC, RE, RF, RX, and RY is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and/or
wherein each R, RA, RB, RE, RF, RX, and RY is independently selected from the list consisting of the structures of LIST 9 as defined herein.

### Claim 15 (depends on 13)

The compound of claim 13, wherein the compound is selected from the group consisting of compounds having the formula of Pt(LA-)(Ly):
wherein LA′ is selected from the group consisting of LA′W1-(Ri)(Rj)(Rk)(Rl), wherein W1 is an integer of from 1 to 37, each Ri, Rj, Rk, and Rl is independently selected from R1-R468, wherein each of LA′1-(R1)(R1)(R1)(R1) to LA′37-(R468)(R468)(R468)(R468) are shown in LIST 7 as defined herein: wherein at least one of Ri, Rj, Rk, or Rl comprises a structure of Formula II;
wherein Ly is selected from the group consisting of LyZ1-(Rs)(Rt)(Ru), wherein Z1 is an integer of from 1 to 38, each of Rs, Rt, Ru, Rv is independently selected from R1 to R468, wherein Ly1-(R1)(R1)(R1) to Ly38-(R468)(R468)(R468) are defined in LIST 8 as defined herein; wherein R1 to R468 have the structures as defined in LIST 9 as defined herein; and/or
wherein the compound is selected from the group consisting of the compounds having the formula of Pt(LA′)(Ly):
wherein LA′ is selected from LA′pi-(Lw)(Rl′)(Rm′)(Rn′)(Ro′) or LA′qi-(Lw)(Rl′)(Rm′)(Rn′)(Ro′)(Rp′);
wherein pi is an integer from 1 to 15; wherein qi is an integer from 16 to 22; wherein w is an integer from 1 to 9; l′, m′, n′, o′ and p′ are each independently an integer of from 1 to 468; Lw is independently selected from the group consisting of L1 to L9; and each of Rl′, Rm′, Rn′, Ro′, and Rp′ is independently selected from the group consisting of R1 to R468, and each of LA′1-(L1)(R1)(R1)(R1)(R1) to LA′15-(L9)(R468)(R468)(R468)(R468) and each of LA′16-(L1)(R1)(R1)(R1)(R1)(R1) to LA′19-(L9)(R468)(R468)(R468)(R468)(R468) is defined in LIST 17 as defined herein;
wherein Ly is selected from the group consisting of the structures shown below:
wherein Ly is selected from LyW-(Rs)(Rt)(Ru)(Rv), wherein W is an integer from 1 to 64; and
each of Rs, Rt, Ru, and Rv is independently selected from the group consisting of R1 to R468, and each of Ly1-(R1)(R1)(R1)(R1) to Ly64-(R468)(R468)(R468)(R468) is defined in LIST 18 as defined herein;
wherein each of R1 to R468 have the structures defined in LIST 9 as defined herein;
wherein L1 to L9 have the following structures as defined in the following LIST 19:

### Claim 16 (depends on 13)

The compound of claim 13, wherein the compound is selected from the group consisting of compounds having the formula of Pt(LA′)(Ly):
wherein LA′ is selected from the group consisting of the structures shown in LIST 15 as defined herein;
wherein Ly is selected from the group consisting of the structures shown in LIST 16 as defined herein; wherein:
RF and RE each independently represent mono to the maximum allowable substitution or no substitution;
each of RF, RE, RX, RY is independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, boryl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, selenyl, and combinations thereof; and
any two substituents may be joined or fused to form a ring.

### Claim 17 (depends on 11)

The compound of claim 11, wherein the compound is selected from the group consisting of the structures from LIST 11 as defined herein and/or wherein the compound is selected from the group consisting of the structures from LIST 20 as defined herein.

### Claim 18

An organic light emitting device (OLED) comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode,
wherein the organic layer comprises a compound having a first ligand LA comprising a structure of Formula I:
wherein moieties A and B are each independently a monocyclic ring or a polycyclic fused ring system, wherein the monocyclic ring or each ring of the polycyclic fused ring system is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring;
wherein Z1-Z4 are each independently C or N;
wherein K1 and K2 are each independently selected from the group consisting of a direct bond, O, S, N(Rα), P(Rα), B(Rα), C(Rα)(Rβ), and Si(Rα)(Rβ);
wherein L is selected from the group consisting of a direct bond, O, S, Se, NR, BR, BRR′, PR, CR, C═O, C═NR, C═CRR′, C═S, CRR′, SO, SO2, P(O)R, SiRR′, and GeRR′;
wherein RA and RB each independently represents mono to the maximum allowable substitution, or no substitution;
wherein each R, R′, Rα, Rβ, RA, and RB are each independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
wherein at least one of RA, RB, moiety A, or moiety B comprises a structure of Formula II:
wherein X1, X3, X4, and X6 are each independently selected from the group consisting of O, S, Se, N, NR, B, BR, BRR′, PR, C, CR, C═O, C═NR, C═CRR′, C═S, CRR′, S, SO, SO2, P, P(O)R, Si, SiRR′, Ge, and GeRR′;
wherein X2 and X5 are each independently selected from the group consisting of N, C and CR;
wherein Z is selected from the group consisting of O, S, Se, B, BR, BRR′, N, NR, C, CRR′, Si, SiRR′, Ge, and GeRR′;
wherein LA is coordinated to a metal M;
wherein represents a single bond or a double bond;
wherein exactly one of the bonds between X1 and X2 and the bond between X2 and X3 is a double bond;
wherein exactly one of the bonds between X4 and X5 and the bond between X5 and X6 is a double bond;
wherein M is selected from the group consisting of Ru, Os, Ir, Pd, Pt, Cu, Ag, and Au;
wherein M may be coordinated to other ligands;
wherein LA may be joined with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and
wherein any two of R, R′, Rα, Rβ, RA, and RB may be joined or fused to form a ring.

### Claim 19 (depends on 18)

The OLED of claim 18, wherein the compound is an emitter, or the compound is a sensitizer, and wherein when the compound is a sensitizer, the OLED further comprises an acceptor selected from the group consisting of a fluorescent emitter, a delayed fluorescence emitter, and combination thereof.

### Claim 20

A consumer product comprising an organic light-emitting device (OLED) comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode,
wherein the organic layer comprises a compound having a first ligand LA comprising a structure of Formula I:
wherein moieties A and B are each independently a monocyclic ring or a polycyclic fused ring system, wherein the monocyclic ring or each ring of the polycyclic fused ring system is independently a 5-membered to 10-membered carbocyclic or heterocyclic ring;
wherein Z1-Z4 are each independently C or N;
wherein K1 and K2 are each independently selected from the group consisting of a direct bond, O, S, N(Rα), P(Rα), B(Rα), C(Rα)(Rβ), and Si(Rα)(Rβ);
wherein L is selected from the group consisting of a direct bond, O, S, Se, NR, BR, BRR′, PR, CR, C═O, C═NR, C═CRR′, C═S, CRR′, SO, SO2, P(O)R, SiRR′, and GeRR′;
wherein RA and RB each independently represents mono to the maximum allowable substitution, or no substitution;
wherein each R, R′, Rα, Rβ, RA, and RB are each independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof;
wherein at least one of RA, RB, moiety A, or moiety B comprises a structure of Formula II:
wherein X1, X3, X4, and X6 are each independently selected from the group consisting of O, S, Se, N, NR, B, BR, BRR′, PR, C, CR, C═O, C═NR, C═CRR′, C═S, CRR′, S, SO, SO2, P, P(O)R, Si, SiRR′, Ge, and GeRR′;
wherein X2 and X5 are each independently selected from the group consisting of N, C and CR;
wherein Z is selected from the group consisting of O, S, Se, B, BR, BRR′, N, NR, C, CRR′, Si, SiRR′, Ge, and GeRR′;
wherein LA is coordinated to a metal M;
wherein represents a single bond or a double bond;
wherein exactly one of the bonds between X1 and X2 and the bond between X2 and X3 is a double bond;
wherein exactly one of the bonds between X4 and X5 and the bond between X5 and X6 is a double bond;
wherein M is selected from the group consisting of Ru, Os, Ir, Pd, Pt, Cu, Ag, and Au;
wherein M may be coordinated to other ligands;
wherein LA may be joined with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and
wherein any two of R, R′, Rα, Rβ, RA, and RB may be joined or fused to form a ring.
